RxSight appoints new CEO
Jul 15, 8:18 PM
RXST
- RxSight has appointed Aziz Mottiwala as its new president and chief executive officer, with the leadership transition taking effect on July 20, 2026.
- Ron Kurtz, M.D., will step down as CEO and remain with the company as chief medical officer, ensuring continuity through his medical expertise and industry experience.
- Mottiwala previously served as chief commercial officer at Tarsus Pharmaceuticals and brings significant experience in commercial strategy and business growth.
- The leadership change is viewed positively, as Mottiwala’s commercial background is expected to strengthen RxSight’s expansion and market development efforts.
Recommendation Rating: Positive – Leadership Transition Strengthens Commercial Focus
RxSight (RXST) has appointed Aziz Mottiwala as its new president and chief executive officer, effective July 20, 2026.
Mottiwala will take over from Ron Kurtz, M.D., who will continue with the company in the role of chief medical officer, allowing RxSight to retain his medical expertise and industry experience.
Before joining RxSight, Mottiwala served as chief commercial officer at Tarsus Pharmaceuticals, bringing extensive experience in commercial strategy and business growth. His appointment is expected to support RxSight’s continued expansion and market development efforts.